Successful absorption of antiretroviral drugs after gastrojejunal bypass surgery following failure of therapy through a jejunal tube

Internal Medicine

Volumn 48, Issue 12, 2009, Pages 1103-1104

  Kamimura, Mahoko ^a   Watanabe, Koji ^a   Kobayakawa, Masao ^a   Mihara, Fuminori ^a   Edamoto, Yoshihiro ^a   Teruya, Katsuji ^a   Kikuchi, Yoshimi ^a   Oka, Shinichi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Absorption; Jejunal tube; Lopinavir; Serum concentration; Viral suppression

Indexed keywords

ABACAVIR; CYCLOPHOSPHAMIDE; DOXORUBICIN; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; CD4 LYMPHOCYTE COUNT; DRUG BLOOD LEVEL; DUODENUM OBSTRUCTION; DUODENUM STENOSIS; ESOPHAGUS CANDIDIASIS; GASTROJEJUNAL BYPASS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINAL FIBROSIS; INTESTINE BYPASS; JEJUNOSTOMY; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; PERCUTANEOUS TRANSHEPATIC DRAINAGE; VIRUS LOAD; VOMITING;

ADMINISTRATION, ORAL; ADULT; ANTI-RETROVIRAL AGENTS; DUODENAL NEOPLASMS; GASTRIC BYPASS; HIV INFECTIONS; HUMANS; INTESTINAL ABSORPTION; JEJUNUM; LYMPHOMA; MALE; PYRIMIDINONES;

EID: 67650069184     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1906     Document Type: Article

References (4)

1. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 148: 728-736, 2008.
2. Kumar GN, Jayanti VK, Johnson MK, et al. Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans. Pharm Res 21: 1622-1630, 2004.
3. Abbott Laboratories. Kaletra (lopinavir/ritonavir) package insert. May, 2008.
4. Boffito M, Lucchini A, Maiello A, et al. Lopinavir/ritonavir absorption in a gastrectomized patient. AIDS 17: 136-137, 2003.